Supplemental figure 2. Proliferation rate of clonally-derived and bulk-cultured iPSCs.
(A) Proliferation of three clonally-derived and two bulk-cultured iPSCs was estimated by increased colony size over four days (four technical replicas per iPSC). (B) Alternatively, equal amounts of cells were seeded in individual wells and counted after 1, 3, and 5 days. Foldincrease in cell counts is depicted in comparison to day 1. The results demonstrate that bulkcultured and clonally-derived iPSCs have similar proliferation rates.
Supplemental figure 3. FACS analysis of cells with episomal GFP expression.
Dot plot analysis demonstrates GFP-expression versus forward scatter in cells transfected with an episomal plasmid for GFP or negative controls. The percentage of GFP-positive cells decays over four weeks. Representative data for three independent experiments are demonstrated.
Supplemental figure 4. Conventional karyotyping of bulk-cultured iPSCs.
To investigate structural and numerical chromosomal alterations we performed conventional karyotyping on QFQ-and GTG-banded metaphases of clonally-derived or bulk-cultured iPSCs. A GTG-banded metaphase of a bulk-cultured iPSC preparation is exemplarily presented. We did not observe karyotypic abnormalities.
Supplemental figure 5. Heatmap of pluripotency genes.
Gene expression of selected pluripotency genes in our data was compared to previously published data on human fetal fibroblasts (hFF1/2/3), ESCs (E1/2) and iPSCs (iPS52, iPS60, iP62 and iPS65; GSE21655). This heatmap demonstrates very similar expression of pluripotency genes in the two different datasets (whereas they are not expressed in the corresponding fibroblasts).
Supplemental figure 6. Gene expression upon in vitro differentiation of iPSCs.
Clonally-derived ("C") and bulk-cultured ("B") iPSCs were differentiated with embryoid-body formation and subsequently cultured on gelatin coated plastic for 7, 13, and 17 days. Differential expression in comparison to the corresponding non-differentiated iPSCs revealed up-regulation of ectodermal (GFAP, NKX6-1, PAX6, SOX1), mesodermal (CD31, CD34, ISL1, TBX3, MYH6), and endodermal markers (AFP, ALB, SOX17). In contrast, OCT4 expression was down-regulated. These data were assessed by RT-qPCR in three biological replica for bulk-cultured iPSCs and two biological replica (with an additional technical replica) for clonally derived iPSCs. Expression of PECAM1 (CD31) and albumin (ALB) may indicate differences between C and B. However, significantly different fold changes were only observed at individual time points and they are probably due to technical noise. Overall, up-regulation of differentiation markers was very similar in clonally-derived and bulk-cultured cells (* = P < 0.01).
Supplemental figure 7.
In vitro differentiation of iLB c1-30m-r12 iPSCs.
(A) Neuroectodermal rosettes were frequently observed upon differentiation of iLB c1-30m-r12 iPSCs. (B) Expression levels of the pluripotency marker OCT4 and ectodermal (PAX6, SOX1), mesodermal (MYH6, CD31, CD34), and endodermal markers (AFP, SOX17, FoxA2). These results were analyzed by RT-qPCR in analogy to supplemental figure 4. Table 2 .
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